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Abstract
Background: In dynamic biological processes, genes, transcription factors(TF) and microRNAs(miRNAs) play vital
regulation roles. Many researchers have focused on the transcription factors or miRNAs in transcriptional or post
transcriptional stage, respectively. However, the transcriptional regulation and post transcriptional regulation is not
isolated in the whole dynamic biological processes, there are few reserchers who have tried to consider the network
composed by genes, miRNAs and TFs in this dynamic biological processes, especially in the mouse lung development.
Moreover, it is widely acknowledged that cancer is a kind of developmental disorders, and some of pathways involved
in tissue development might be also implicated in causing cancer. Although it has been found that many genes
differentially expressed during mouse lung development are also differentially expressed in lung cancer, very little work
has been reported to elucidate the combinational regulatory programs of such kind of associations.
Results: In order to investigate the association of transcriptional and post-transcriptional regulating activities in the
mouse lung development, we define the significant triple relations among miRNAs, TFs and mRNAs as circuits.
From the lung development time course data GSE21053, we mine 142610 circuit candidates including 96 TFs, 129
miRNAs and 13403 genes. After removing genes with little variation along different time points, we finally find
64760 circuit candidates, containing 8299 genes, 50 TFs, and 118 miRNAs in total. Further analysis on the circuits
shows that the circuits vary in different stages of the lung development and play different roles. By investigating
the circuits in the context of lung specific genes, we identify out the regulatory combinations for lung specific
genes, as well as for those lung non-specific genes. Moreover, we show that the lung non-specific genes involved
circuits are functionally related to the lung development. Noticing that some tissue developmental systems may be
involved in tumourigenesis, we also check the cancer genes involved circuits, trying to find out their regulatory
program, which would be useful for the research of lung cancer.
Conclusions: The relevant transcriptional or post-transcriptional factors and their roles involved in the mouse lung
development are both changed greatly in different stages. By investigating the cancer genes involved circuits, we
can find miRNAs/TFs playing important roles in tumour progression. Therefore, the miRNA-TF-mRNA circuits can be
used in wide translational biomedicine studies, and can provide potential drug targets towards the treatment of
lung cancer.
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Background
Although it is not completely understood what and how
many factors play main roles in the process of lung devel-
opment, several factors that invovle in the dynamic pro-
cess and play important roles have been confirmed by the
biologist. Through analysis of gene expression data at dif-
ferent stages of lung development in the field of molecular
biology, a series of novel temporal regulations, target
genes, transcription factors, and candidate regulatory path-
ways have been observed during these dynamic biological
processions [1,2]. The mammalian lung development can
be divided into six stages, ranging from embryos to mature
lung [1,3]. At these different stages of lung development,
the involved regulatory elements should include both
housekeeping and stage-specific ones.
It is well known that transcription factors (TFs) and
microRNAs (miRNAs) are key regulators for gene
expression regulation in high eukaryotes. The transcrip-
tion factor play a key role in the transcription process
which controls the activity of a gene by determining
whether the gene’s DNA is transcribed. The first step of
the process of transcription is to convert the gene’s
DNA into a complementary coding mRNA molecule;
then in the second step, the mRNA molecule is trans-
lated as an amino acid sequence of a protein [4]. While,
miRNAs are a class of short RNA (21-24 nt) sequences
that can regulate the expression of target genes at the
post-transcriptional level [5]. Based on the pairing of
miRNAs and their target sites on corresponding
mRNAs, the complexes can inhibit translation by either
degrading the mRNAs, or by blocking translation with-
out degrading the targets [5].
There have been many studies focusing on investigat-
ing the functions of miRNAs or TFs, respectively. For
examples, Dong et al. investigated the dynamical miRNA
and mRNA regulation patterns for lung development by
using statistical and computational methods [6]. Bandyo-
padhyay et al. obtained a global perspective of miRNA
dysregulation in multiple cancer types by analyzing the
differential expression patterns of specific miRNAs in
cancer tissues [7]. There are also some studies consider-
ing the miRNA regulatory network [8-10] or TFs and
target genes regulatory networks [11]. As a result, many
computational tools have been proposed to predict the
miRNA-mRNA regulations (EMBL [12], Miranda [13],
SNMNMF[14,15], PicTar [16], mirConnX [17], and Tar-
getScan [18]), or the TF-mRNA regulations (TRRD[19],
JASPAR[20], and TRANSFAC [21,22]). Recently there
are several attempts to discover the combinational links
between miRNAs, TFs and target mRNAs (genes)
[23-26], however, it is obviously that not enough atten-
tions are paid on the regulatory combinations to under-
stand the molecular mechanism of the complicated
biological processes. In our preliminary version of this
work [27], we have proposed a methodology to consider
the regulatory combinations involved in the mouse lung
development, and found some regulatory combinations
in different lung developmental stages. Our earlier work
has only considered the context of lung specific genes.
However, the lung developmental process is complicated,
which may be involved in not only lung specific but also
lung non-specific genes and their regulators. Therefore,
not just lung specific genes, but other tissue genes should
also be considered to systematically investigate the regu-
latory mechanism of lung development.
It is widely acknowledged that cancer is a kind of com-
plex developmental disorders, and some controlling devel-
opmental systems might also be involved in causing
cancer. Lung cancer is the highest mortality cancer [28]
and thus has recently attracted more and more attentions.
Bonner et al. [29] have examined the genetic changes
occurring during lung carcinogenesis by analyzing tissues
from mice normal lungs and cancers on Affymetrix
U74Av2 gene chips, and found that 24 developmentally
regulated genes are aberrantly expressed in lung tumours.
Kopantzev et al. [29,30] have found that opposite differ-
ences by comparing gene expression profiles in human
non-small cell lung carcinomas and in human fetal lung
development. Understanding the association of the regula-
tory mechanisms between lung development and lung
tumour might provide novel insight of the lung carcino-
genesis, which is helpful for the treatment of the lung
cancer.
To address above questions, in this paper we define
the significant triple relation among miRNA, TF and
mRNA as a circuit, and propose to detect the circuits to
identify the non-trivial regulatory combinations in the
lung development of mouse. Then we analyze the com-
binations across the lung development and find out
stage-specific combinations. According to the lung
specific genes collected from the tissue specific gene
database TiSGeD [31], we further distinguish circuits
specific to lung development from those irrelevant to
the lung developmental process. Finally, we consider the
genes that have been shown to be related to cancers in
literature and investigate their involved circuitsto find
out the multiple roles of miRNAs and TFs in lung
development and tumour progression. Our results give a
systematic view for understanding the alteration of tran-
scriptional or post-transcriptional regulatory factors and
their roles involved in the mouse lung development and
tumour progression.
Methods
In this paper, we define the triple relationship among
mRNA, TF and miRNA as a circuit (Figure 1) in which
the information from transcription and post-transcription
is fused to impose and recognize non trivial regulatory
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combinations [32]. Based on the definition, we integrate
information on miRNAs, TFs, genes, and their interactions
to detect and investigate the circuits related to the biologi-
cal process (Figure 2).
Data resources
(1) Lung development time-course data collected from
two mouse samples: GSE21053 [6]. GSE21053 consists
of GSE20152 and GSE20954, corresponding to miRNA
and gene expression data respectively. The expression
values are measured at seven time points: embryo day
12, 14, 16, and 18; and postnatal day 2, 10 and 30.
(2) Lung specific genes: The Tissue-Specific Genes
Database (TiSGeD) [31]. TiSGeD provides comprehen-
sive information of genes specific to lung and other tis-
sues collected from biomedical literatures. By setting
SPM [31] threshold as 0.3, we extract 511 lung specific
genes from TiSGeD, 455 of them are in common with
GSE20954 and will be used for further study.
(3) Cancer related genes: we collect all the 487 cancer
related genes from Cancer Gene Census[33], 118 of
which are overlapped with the lung developmental genes,
and 19 of which are also found to be lung specific genes.
(4) miRNA-gene pairs: miRanda [34], TargetScan [18]
and circuitDB [35].
(5) TF-gene pairs: KEGG [36], Tred [37] and and cir-
cuitDB [35].
(6) miRNA-TF pairs: circuitDB [35].
Figure 1 The circuit structure.
Figure 2 Analysis procedure of circuits.
Liu et al. BMC Systems Biology 2013, 7(Suppl 2):S11
http://www.biomedcentral.com/1752-0509/7/S2/S11
Page 3 of 14
Extraction of miRNA-TF-mRNA circuit candidates
The flowchart of extracting miRNA-TF-mRNA circuit
candidates is shown in Figure 3. First, we extract miRNAs
from GSE20152, TFs and genes from GSE20954 (we just
use the coding genes to represent the TFs in this work).
We preprocess gene expression data by filtering out
those with small variances along all seven time points. As
a result, there remain 8299 genes for further study. Then
we extract miRNA-gene, TF-gene and miRNA-TF pairs
from the data described above. All pairs are combined
into potential miRNA-TF-mRNA circuits. As a result, we
find 64760 circuit candidates, containing 8299 genes, 50
TFs and 118 miRNAs in total.
Detection of significant circuits relevant to lung
development
For each pair <i, j> in a circuit candidate (i and j are
two vectors of expression data along a period of time
points), we evaluate the significance of the pair-wise
relationship at a specific stage of lung development by
using Pearson correlation coefficient R(i, j):
R(i, j) =
E[(i − µi)∗(j − µj)]√
E[(i − ui)∗(i − µi)]E[(j − µj)∗(j − µj)]
where E is the mathematical expectation and μi is the
mean of vector i. We use the permutation test to evalu-
ate the significance of the correlation and set the
p-value threshold as 0.05. Only when all of three pairs
in the same circuit candidate are significant, can it be
regarded as a circuit at the specific period of lung
development.
Results and discussion
Figure 4 displays the result obtained by two-way cluster-
ing genes along 7 time points of the mouse lung develop-
ment. It can be seen that the mouse lung development is
mainly gone through two stages. The first stage is from
time point 1 to time point 3 and the second stage is from
time point 4 to time pint 7. We notice that although time
points 1-4 correspond to embryo days 12, 14, 16 and 18,
time point 4 is grouped with time points 5-7 (postnatal
days 2, 10 and 30). Thus we can envision that the
Figure 3 Extraction of circuit candidates.
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molecular mechanism of pseudoglandular and canalicular
of lung (embryo days 12-17) is very different with that of
saccular and alveolar (≥ embryo day 17) which continues
until a period of time after birth (postnatal days 2, 10,
and 30). Furthermore, we have found that time point 7
(postnatal day 30) are different with time points 4-6
though they are grouped together, which may be due to
the fact that postnatal day 30 corresponds to the matura-
tion at the microvasculature stage. Therefore, we only
consider time points 1-3 and 4-6 of the lung develop-
ment and respectively call them as early and late stages
hereinafter.
From 64760 collected circuit candidates, we have
mined 1046 circuits including 10 TFs, 574 genes and 19
miRNAs in the early stage, and 195 circuits including 7
TFs, 147 genes and 13 miRNAs in the late stage. To see
how the circuits change across the lung development,
we have also mined 3201 circuits involved in the whole
six time points of the lung development, including 13
TFs, 1565 genes and 28 miRNAs. Figure 5 illustrates the
overlap circuits among the early, late and whole stages.
It can be seen that there are different circuits involved
at different stages, which means that the roles of TFs/
miRNAs/genes within the circuits vary greatly during
the lung development, and they involve in different bio-
logical pathways at different stages.
Dynamic circuits involved in the lung development
The circuits in the early and late stages of the lung
development are shown in Figure 6 (see Additional file
1 for the details). We can see that different circuits
involve in different stages. Even for those common miR-
NAs/TFs/genes, they participate in different circuits in
two stages, showing that they may play varied roles dur-
ing the lung development. For example, at the early
stage the target genes of miRNA mir-135b are Arhgef9,
Car3, Ccdc88a, Cth, Dcx, Efnb3, Faah, Gabra4, Ints2,
Mrps25, Ms4a6d, Myo18a, Pcdh18, Pus1, Sip1, Tnpo1,
and Wdhd1. However, at the late stage the target genes
of miRNA mir-135b are changed to Ccdc88a, Cdh10,
Cth, Pcdhb3, Rnf138, Trpc6, and Ttyh2.
We further plot the expression profiles of common
miRNAs/TFs/genes in Figure 7 to show the variations of
their activities. From Figure 7 we can also see that the
miRNAs/TFs/genes may be involved in different func-
tion modules in different stages.
TF overlap (Figure 5(b))
We have found that there are four TFs: BACH2, IRF1,
MYC and HOXA4, which are participated in the early
and late stages. BACH2 and HOXA4 are down-regu-
lated in the early stage and up-regulated in the late
stage (HOXA4 is one point time lagged); and IRF1 is
up-regulated while MYC is down-regulated across all
Figure 4 Two-way clustering of genes.
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the time points (Figure 7(a)). It has been shown that
Hox genes are implicated in the lung development and
the patterning, and the HOXA4 and HOXA5 are likely
to be involved in the patterning of the mouse lung [38].
According to the GO term GO:0048513, IRF1 and MYC
also have the function related to the organ development.
It is noticeable that MYC amplification is found to be a
prognostic marker of early-stage lung adenocarcinoma
[39], and BACH2 has also been researched in the cancer
treatment [40], which shows that the tumour has asso-
ciation with the developmental process.
MiRNA overlap (Figure 5(c))
We have found that there are five miRNAs participated in
both the early and late stages: mmu-mir-200a, mmu-mir-
200b, mmu-mir-135b, mmu-mir-494 and mmu-mir-503.
They show similar expression profiles along six time
points of the lung development: first down-regulated and
then up-regulated (Figure 7(b)). The miR-200 family is
believed to play an essential role in the tumour suppres-
sion. It has been shown to play an important role in fibro-
tic lung diseases [41]. The mir-135b, mir-503b and mir-94
are also found to have relationship with lung cancer
Figure 5 Overlap in different lung development stages. (a) Circuits overlap. (b) TF overlap. (c) miRNA overlap. (d) gene overlap.
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[42-44]. We think that miRNAs related to cancers may
more likely participate in regulatory programs of both
lung developmental stages.
Gene overlap (Figure 5(d))
We have found that there are 24 common genes roughly
divided into two groups (Prdx6, B3gnt2, Car3, Cbx1,
Ccdc88a, Cdh13, Cpeb1, Cth, Dclk1, Dnajc9, Fgd4, Il1rap,
Ipo9, Klf4, Klhl29, Mpp7, Pde7a, Pdk4, Per1, Phf20, Plat,
Rnf138, Rtn4, Tdrkh) occurring in the early and late stages
(Figure 7(c)). It has been shown that most of them are
related to tumours, such as Prdx6 [45], Cdh13 [46], Klf4
[47], and so on. Once again, we suggest that common
genes in early and late stages of lung development may be
more likely related to tumourigenesis even if they are not
shown to be cancer genes.
Dynamic regulations of circuits in the context of lung
specific genes
Reinvestigating Figure 6 in the context of the lung specific
genes, we have found that not only are lung specific but
also non-specific genes related to the lung development
(their involved circuits are shown in Figure 8 and Figure 9,
respectively).
Specifically, we have detected out some regulators for
lung non-specific genes, i.e., TF: ATF6, DBP (early), and
TBP (late); miRNAs: mmu-mir-152, mmu-mir-187,
mmu-mir-320, mmu-mir-326, mmu-mir-451 (early), and
mmu-mir-494 (late). We think that they should have
functions related to the lung development even though
their regulating genes are not lung specific. For examples,
ATF6 is an endoplasmic reticulum (ER) stress-regulated
transmembrane transcription factor, and specific ER
stress signaling transmitted by ATF6 leads to naturally
occurring apoptosis during the muscle development [48];
DBP is a multifunctional protein found in plasma, ascitic
fluid, cerebrospinal fluid, and urine and on the surface of
many cell types; miR-320 plays a role in neuronal devel-
opment[49]. According to the functional annotations of
the regulators, it seems that they can actually play roles
in the lung development in an indirect way.
To analyze the dynamic regulations in different stages
of the lung development, we have constructed the
Figure 6 Circuits in early and late stages of the lung development. Circuits in red and green rectangles are of early and late stages
respectively; and circle, square and triangle nodes stand for miRNAs, TFs and genes.
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circuit network of the common TFs, miRNAs and gene
in different lung development stages, in the context of
lung specific genes (as shown in Figure 10).
From Figure 10, we can see that different group of genes
involved in early and late stages of the lung development,
regulated by different TF-miRNA combinations. Moreover,
some common genes/TFs/miRNAs involved in different
stages show different functions. Gene Prdx6 is involved in
one circuit in the early stage (IRF1~mmu-mir-503~Prdx6),
while involved in the other two circuits containing the
Figure 7 Profiles of common TFs, miRNAs and genes at two stages of lung development.
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Figure 8 The lung specific genes involved circuits at different stages. Circuits in red and green rectangles are of early and late stages
respectively; and circle, square and triangle nodes stand for miRNAs, TFs and genes respectively.
Figure 9 Lung non-specific genes involved circuits. TF and miRNA in dashed yellow circle box are in lung development circuit network but
not are included in lung tissue specific circuit network.
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same miRNA (MYC~mmu-mir-19a~Prdx6, IRF1~mmu-
mir-19a~Prdx6) in the late stage. Thus, in different stages
of the lung development, Prdx6 may show different func-
tions which are mainly determined by mmu-mir-503 and
mmu-mir-19a, respectively.
We have also noted that mmu-mir-200a play some roles
in the early stage by cooperating with MEIS1, while play
other roles in the late stage by cooperating with BRCA1
together. By cooperating with different miRNAs, transcript
factors BACH2, MYC or IF1 can co-regulate different
genes in the early and late stages, respectively.
Functional specificities of circuits in lung development
We have found that the miRNA and the TF usually have
dynamical regulation programs at different stages during
mouse lung development. In particular, the involved genes
usually have opposite expression profiles at different stages
(Figure 4). To computationally explore the potential func-
tions of the dynamically regulated genes in lung develop-
ment, we have employed biological process and pathway
analysis on the lung specific genes.
Using DAVID tool [50], we get all enriched biological
processes (Table 1) and pathways (Table 2) (P-value <
0.05). From Table 1, we have found several GO terms
relevant to lung development. For example, three GO
terms related to phosphorus function involve in the early
stage: GO:0006793 GO:0006796 and GO:0016310. As
known to all, inorganic phosphate (Pi) plays a critical role
in diverse cellular functions and low Pi affects the lung
development of mice by disturbing protein translation
[51]. The GO:0051094 (positive regulation of developmen-
tal process) and GO:0035023 (regulation of Rho protein
signal transduction) are also very relevant to the lung
development. Rho protein plays a significant role in inhi-
biting lung development [52] while the ROCK2 plays a
major role in the formation of the gas exchange units and
as a sensor for accelerating the lung development [53,54].
In Table 2, the pathways indicated in bold have been
reported to be associated with lung. For mmu04810,
Actin cytoskeleton plays a role in human pulmonary
artery ECS [55]. For mmu00740, lung remodelling
induced by exposure of total parenteral nutrition to
ambient light is due to the interaction between vitamin C
and peroxides generated by the exposure of riboflavin to
light [56]. For mmu04060, the analysis of lung adenocar-
cinoma tissue specimens have demonstrated that the
Figure 10 The circuit network of common nodes at different stages. Circuit network of the common TFs, miRNAs and gene in different
lung development stages, in the context of lung specific genes.
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genes involved in these biological pathways have high
rates of over-expression [57]. For mmu00230, metabolic
changes in the lung as a result of ventilation-induced
lung injury are reflected by an increased level of purine
in the bronchoalveolar lavage fluid and that purine may,
thus, serve as an early marker for ventilation-induced
lung injury [58]. For mmu00533, the pathways of Keratan
sulphate biosynthesis are associated with prostate cancer
and small cell lung cancer[59].
Investigation on cancer genes involved in circuits
As it is known to all, the developmentally regulated genes
may be involved in lung tumours. Therefore we pick out
the circuits related to the cancer genes from Figure 4
(shown in Figure 11). From Figure 11, we have identified
out the regulating miRNAs and TFs of the 118 cancer
genes and found out there are 38 circuits including 7 TFs,
14 miRNAs and 25 genes at the early stage; 6 circuits with
2 TFs, 4 miRNAs and 4 genes at the late stage. Any abnor-
mal expression of the regulatory combinations may result
in tumour. Compared to the cancer genes, the number of
miRNAs/TFs is obviously smaller, which makes it more
convenient to the research or treatment of cancer. From
Figure 11, we have further extracted those lung specific
genes involved circuits (shown in Figure 12), which con-
tain 5 genes, 1 TFs and 6 miRNAs. We have noticed that
miRNAs are from mir-200 family (mir-200a, mir-200b and
mir-429), mir-29 family (mir-29a and mir-29c) and mir-
150 family, they are all related to lung cancer[60,61]. Spe-
cifically, miR-200 miRNAs are involved in cancer metasta-
sis[62]; mir-150 functions in hematopoiesis, and regulates
genes whose downstream products encourage differentiat-
ing stem cells towards becoming megakaryocytes rather
than erythrocytes [63]; mir-29 miRNAs activates p53, the
tumour suppressor [64]. MEIS1 is a conserved transcrip-
tion factor of the TALE-homeodomain class, expressed in
a wide variety of tissues during development, and known
to be required for the development of many organs in ver-
tebrates and invertebrates. It has also been found incor-
rectly expressed in a number of tumour types, such as
acute myeloid leukemia [65], lung adenocarcinoma
tumours [66], nephroblastomas [67], and so on. Therefore,
the circuits shown in Figure 12 uncovers that the regula-
tory combinations of MEIS1 and mir-200/mir-29/mir-150
miRNAs play roles in the early stage in the lung develop-
ment, while their abnormal expressions may result in the
tumour progression.
Table 1 Top 10 GO biological process terms in different periods
Period NO Term P-value
1 GO:0006793~phosphorus metabolic process 5.40E-05
2 GO:0006796~phosphate metabolic process 5.40E-05
3 GO:0016310~phosphorylation 1.21E-04
4 GO:0045596~negative regulation of cell differentiation 2.60E-04
Early 5 GO:0051056~regulation of small GTPase mediated signal transduction 3.32E-04
6 GO:0006468~protein amino acid phosphorylation 5.28E-04
7 GO:0035023~regulation of Rho protein signal transduction 5.30E-04
8 GO:0007167~enzyme linked receptor protein signaling pathway 7.96E-04
9 GO:0022604~regulation of cell morphogenesis 0.001564
10 GO:0051094~positive regulation of developmental process 0.002006
1 GO:0006928~cell motion 7.08E-05
2 GO:0016477~cell migration 0.001009
3 GO:0030030~cell projection organization 0.002595
4 GO:0017148~negative regulation of translation 0.002614
Late 5 GO:0010558~negative regulation of macromolecule biosynthetic process 0.00269
6 GO:0010608~posttranscriptional regulation of gene expression 0.002856
7 GO:0032268~regulation of cellular protein metabolic process 0.003146
8 GO:0031327~negative regulation of cellular biosynthetic process 0.003426
9 GO:0048870~cell motility 0.003474
10 GO:0051674~localization of cell 0.003474
Table 2 Significant pathways in different periods
Period No Term P-value
1 mmu04512:ECM-receptor interaction 0.005104
2 mmu04810:Regulation of actin cytoskeleton 0.006057
Early 3 mmu04115:p53 signaling pathway 0.014693
4 mmu05200:Pathways in cancer 0.028372




Late 1 mmu00230:Purine metabolism 0.011819
2 mmu00533:Keratan sulfate biosynthesis 0.013904
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Figure 11 Dynamic circuits related to cancer genes. Circuits in red and green dashed box are of early and late stages respectively; and circle,
square and triangle nodes stand for miRNAs, TFs and genes.
Figure 12 Lung specific cancer genes involved circuits showing the association between lung development and tumourigenesis.
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Conclusions
In this work, we have mined and investigated the miRNA-
TF-mRNA circuits involve in mouse lung development.
The results have shown that the relevant transcriptional or
post-transcriptional factors and their roles involved in lung
development greatly vary at different stages. By considering
those circuits associated with lung specific genes, we have
identified out the dynamic regulatory interaction of
miRNA-TF-mRNA circuits in different lung development
stages. By investigating the circuits in the context of cancer
genes, we have detected out some circuits related to the
lung cancer, thus illustrating the association between the
lung development and the tumourigenesis. Therefore, the
miRNA-TF-mRNA circuits can be used in wide transla-
tional biomedicine studies, and can provide potential drug
targets towards the treatment of lung cancer.
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Additional file 1: The excel file for the circuits shown in Figure 6.
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